Cardiology Associations

This page includes news coverage of cardiology societies and associations. Follow these links for specific cardiology society news pages: American College of Cardiology (ACC), American Heart Association (AHA), American Society of Echocardiography (ASE), American Society Nuclear Cardiology (ASNC), European Society of Cardiology (ESC), Heart Rhythm Society (HRS), Society for Cardiovascular Angiography Interventions (SCAI), Society of Cardiovascular Computed Tomography (SCCT), Transcatheter Cardiovascular Therapeutics (TCT), and Vascular Interventional Advances (VIVA).

How anti-DEI healthcare policies are impacting patient care
All over the United States, countless research projects designed to improve outcomes have lost funding or been shut down. Even screening efforts targeting patients in impoverished communities have been impacted by these policies.
Heart attack deaths are way down after decades of breakthroughs—but other risks have skyrocketed
Researchers explored more than 52 years of data, highlighting several key trends in the Journal of the American Heart Association.
TTVR with Evoque system linked to positive real-world outcomes after 30 days
According to early real-world data, the FDA-approved Evoque TTVR device is associated with positive outcomes when used to treat severe tricuspid regurgitation.
A closer look at world’s first TAVR patient treated with new cerebral embolic protection device
The device covers three vessels at once and can be deployed through the patient's TAVR access site. Researchers shared their first-in-human experience in JACC: Case Reports.
Society of Thoracic Surgeons provides on-the-go risk evaluations with new mobile app
The STS Risk Calculator App, available on both iOS and Android devices, gives users improved access to real-time risk assessments.

HeartPoint Global Shark Tank Intellistent

New pediatric interventional device for PAH wins ‘Shark Tank’ event at TCT 2023

The first-place finish earned HeartPoint Global $20,000 in prize money.

Late-breaking clinical trials at TCT 2023 could lead to FDA approvals for Abbott, Boston Scientific

Will a coronary drug-coated balloon finally gain full approval from the FDA? New data presented at TCT 2023 seems to suggest it just might happen.

PARTNER 3, Evolut and more: TAVR takes the spotlight in 4 late-breaking clinical trials at TCT 2023

All eyes were on TAVR during the first round of late-breaking clinical trials at TCT 2023 in San Francisco. Researchers shared key updates related to devices from Edwards Lifesciences, Medtronic, Boston Scientific and JenaValve Technology.

Ziad Ali, MD, explains the ILUMIEN IV trial results for OCT Vs. Angiography.

ILUMIEN IV: OCT adds value over angiography alone, fails to improve outcomes

Ziad Ali, MD, discusses the mixed results of the ILUMIEN IV trial comparing OCT vs angiography alone.

Akhil Narang, MD, director of the echocardiography laboratory at Northwestern Medicine explains the latest trends in structural heart interventional imaging. #ASE #ASE23 #ASE2023 #structuralheart #echofirst

The evolving roles of TEE and ICE in structural heart interventions

Akhil Narang, MD, explained that the two technologies can be used together to deliver high-quality patient care.

Shockwave Medical C2+ catheter TCT 2023 announcement

Shockwave Medical introducing more efficient IVL catheter to US market at TCT 2023

According to Shockwave, the updated IVL catheter can deliver 50% more pulses than its previous offering.

Radial access shows potential to ‘revolutionize’ care for peripheral artery disease

Radial access provides interventional cardiologists with a safe, effective alternative to femoral access during peripheral artery interventions.

SAVR associated with ‘excellent’ long-term survival rates, new research confirms

Even as TAVR continues to build momentum as the go-to treatment option for many patients, researchers are keeping a close eye on the long-term safety and effectiveness of SAVR.

Cardiology Associations

How anti-DEI healthcare policies are impacting patient care

Heart attack deaths are way down after decades of breakthroughs—but other risks have skyrocketed

TTVR with Evoque system linked to positive real-world outcomes after 30 days

A closer look at world’s first TAVR patient treated with new cerebral embolic protection device

Society of Thoracic Surgeons provides on-the-go risk evaluations with new mobile app